[1]
B. N. Dang, H. T. Vo, and V. D. Nguyen, “CLINICAL, PARACLINICAL FEATURES, OUTCOMES, AND ASSOCIATED FACTORS OF DOSE-DENSE 4AC–4P ADJUVANT CHEMOTHERAPY IN HIGH-RISK BREAST CANCER”,
CTJUMP
, no. 102, pp. 35–42, Aug. 2026.